You have 9 free searches left this month | for more free features.

Leukemia, Lymphoid

Showing 5276 - 5300 of 6,227

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Relapsed or Refractory T-cell Acute Lymphoblastic Leukaemia, B-cell Precursor Acute Lymphoblastic Leukaemia, T-cell

Terminated
  • Relapsed or Refractory T-cell Acute Lymphoblastic Leukaemia
  • +2 more
  • Vienna, Austria
  • +5 more
Oct 23, 2012

Preleukemia, Myeloproliferative Disorders, Lymphoma Trial in Chicago (Fludarabine, Melphalan, Campath)

Terminated
  • Preleukemia
  • +4 more
  • Chicago, Illinois
    The Uniiversity of Chicago
Mar 14, 2014

Leukemia Trial in Houston (Procrit (epoetin alfa))

Completed
  • Leukemia
  • Procrit (epoetin alfa)
  • Houston, Texas
    UT MD Anderson Cancer Center
Jul 24, 2012

Accelerated Phase Chronic Myelogenous Leukemia, Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Chronic Phase Chronic

Terminated
  • Accelerated Phase Chronic Myelogenous Leukemia
  • +3 more
  • Aurora, Colorado
  • +1 more
Apr 1, 2014

Chronic Lymphocytic Leukemia Trial in Houston (Campath-1H, Rituximab)

Completed
  • Chronic Lymphocytic Leukemia
  • Houston, Texas
    University of Texas - MD Anderson Cancer Center
Aug 1, 2012

MALT, Nodal Marginal Zone B-cell Lymphoma, Recurrent Adult Burkitt Lymphoma Trial in Stanford (biological, drug, other)

Terminated
  • Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue
  • +33 more
  • oblimersen sodium
  • +3 more
  • Stanford, California
    Stanford University
Jan 24, 2013

Chronic Lymphocytic Leukemia Trial in United States (HCD122)

Terminated
  • Chronic Lymphocytic Leukemia
  • La Jolla, California
  • +4 more
Sep 28, 2012

Acute Myeloid Leukemia Trial in Toronto (Elesclomol Sodium)

Unknown status
  • Acute Myeloid Leukemia
  • Elesclomol Sodium
  • Toronto, Ontario, Canada
    Princess Margaret Hospital
Jan 31, 2014

AIDS-related Peripheral/Systemic Lymphoma, AIDS-related Primary CNS Lymphoma, Anaplastic Large Cell Lymphoma Trial in Pittsburgh

Completed
  • AIDS-related Peripheral/Systemic Lymphoma
  • +52 more
  • Pittsburgh, Pennsylvania
    University of Pittsburgh
Feb 6, 2013

Chronic Lymphocytic Leukemia, Leukemia Trial in Houston (Lenalidomide)

Completed
  • Chronic Lymphocytic Leukemia
  • Leukemia
  • Houston, Texas
    UT MD Anderson Cancer Center
Aug 1, 2012

Colon Cancer, Colorectal Cancer Trial in Los Angeles (capecitabine, imatinib mesylate)

Completed
  • Colon Cancer
  • Colorectal Cancer
  • capecitabine, imatinib mesylate
  • Los Angeles, California
    USC/Norris Cancer Center
May 20, 2014

Leukemia, Lymphoma Trial in Philadelphia (rituximab, epirubicin HCl)

Completed
  • Leukemia
  • Lymphoma
  • rituximab
  • epirubicin hydrochloride
  • Philadelphia, Pennsylvania
    Fox Chase Cancer Center
Jul 10, 2013

Chronic Lymphocytic Leukemia, Leukemia, Tumors Trial in Tianjin (Bendamustine Hydrochloride Injection, Chlorambucil)

Unknown status
  • Chronic Lymphocytic Leukemia
  • +2 more
  • Tianjin, China
    Hematologic hospital of Chinese academy of medical sciences
Aug 3, 2012

Brain Tumor, Acute Lymphoblastic Leukemia Trial in Memphis (Computerized working memory training program (intervention),

Completed
  • Brain Tumor
  • Acute Lymphoblastic Leukemia
  • Computerized working memory training program (intervention)
  • Computerized working memory training program (control)
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Apr 28, 2014

Leukemia, Lymphoma Trial in Boston, Burlington (thalidomide)

Completed
  • Leukemia
  • Lymphoma
  • Boston, Massachusetts
  • +1 more
Jun 25, 2013

Advanced Hematologic Malignancies, Leukemia, Preleukemia Trial in Chicago (Clofarabine, Melphalan, Campath)

Completed
  • Advanced Hematologic Malignancies
  • +2 more
  • Chicago, Illinois
    The University of Chicago
Jan 9, 2014

Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Tumor Trial in New Brunswick (rituximab, therapeutic allogeneic

Terminated
  • Leukemia
  • +2 more
  • rituximab
  • therapeutic allogeneic lymphocytes
  • New Brunswick, New Jersey
    Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Me
Sep 13, 2013

Leukemia Trial in Canada, United States (temozolomide)

Completed
  • Leukemia
  • Stanford, California
  • +15 more
Feb 18, 2014

Leukemia Trial in Cleveland (alemtuzumab)

Completed
  • Leukemia
  • alemtuzumab
  • Cleveland, Ohio
    Ireland Cancer Center
Jan 7, 2014

Adenocarcinoma of the Colon, Stage III Colon Cancer Trial in Chicago (leucovorin calcium, fluorouracil, irinotecan HCl)

Completed
  • Adenocarcinoma of the Colon
  • Stage III Colon Cancer
  • leucovorin calcium
  • +3 more
  • Chicago, Illinois
    Cancer and Leukemia Group B
Oct 7, 2013

Leukemia, Chronic Lymphocytic Leukemia Trial in Houston (Oral Clofarabine)

Withdrawn
  • Leukemia
  • Chronic Lymphocytic Leukemia
  • Oral Clofarabine
  • Houston, Texas
    The University of Texas M.D. Anderson Cancer Center
Jul 31, 2012

Leukemia, Lung Cancer, Lymphoma Trial in New York (azacitidine, sodium phenylbutyrate)

Completed
  • Leukemia
  • +5 more
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Jun 20, 2013

Non-Hodgkin Lymphoma Trial in Worldwide (doxycycline (tetracycline))

Completed
  • Non-Hodgkin Lymphoma
  • doxycycline (tetracycline)
  • Providencia, Santiago, Chile
  • +5 more
Nov 22, 2013

Chronic Lymphocytic Leukemia, Leukemia Trial in Houston (Clofarabine)

Terminated
  • Chronic Lymphocytic Leukemia
  • Leukemia
  • Houston, Texas
    The University of Texas M.D. Anderson Cancer Center
Jul 31, 2012

Lymphoma, Solid Tumor Trial (carbendazim)

Unknown status
  • Lymphoma
  • Unspecified Adult Solid Tumor, Protocol Specific
  • (no location specified)
Sep 19, 2013